Spots Global Cancer Trial Database for vehicle
Every month we try and update this database with for vehicle cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| The Effect of Topical Imipramine on Pain and Effectiveness of Topical Photodynamic Therapy | NCT05688904 | Imipramine Photodynamic Th... Actinic Keratos... | Imipramine Vehicle | 18 Years - | Wright State University | |
| ALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant Recipients | NCT00865878 | Actinic Keratos... Skin Neoplasms | Aminolevulinic ... Vehicle | 18 Years - | DUSA Pharmaceuticals, Inc. | |
| A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients | NCT00961896 | Treatment for B... | Vehicle LDE225 0.25% LDE225 0.75% | 18 Years - 75 Years | Novartis | |
| Study of A-101 Topical Solution for the Treatment of Common Warts | NCT03687372 | Common Wart | A-101 vehicle | 2 Years - | Aclaris Therapeutics, Inc. | |
| Evaluation of Efficacy and Safety of BF-200 ALA Used With Photodynamic Therapy in Patients With Actinic Keratosis. | NCT02799082 | Actinic Keratos... | Vehicle BF-200 ALA | 18 Years - 85 Years | Biofrontera Bioscience GmbH | |
| Efficacy, Safety and Tolerability of Topically Applied LDE225 Cream (Hedgehog Pathway Inhibitor) in Adult Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS) | NCT03070691 | Basal Cell Carc... | LDE225B Vehicle | 18 Years - | Novartis | |
| Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp | NCT03024060 | Actinic Keratos... | ALA Vehicle IBL 20 mW IBL 10 mW | 18 Years - | DUSA Pharmaceuticals, Inc. | |
| Topical NVN1000 for the Treatment of External Genital and Perianal Warts | NCT02462187 | Genital Warts Perianal Warts | NVN1000 8% Gel NVN1000 16% Vehicle NVN1000 24% | 18 Years - 50 Years | Novan, Inc. | |
| A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp | NCT01541553 | Actinic Keratos... | Cryotherapy Vehicle Ingenol metabut... | 18 Years - | LEO Pharma | |
| Bioequivalence Study to Compare Sol-Gel Technologies' 5-FU Cream With Efudex® (5-FU) Cream | NCT03727074 | Actinic Keratos... | 5-FU Cream Efudex® Vehicle | 18 Years - | Sol-Gel Technologies, Ltd. | |
| Safety and Efficacy Double Blind Vehicle Controlled Study of 15% AS101 Gel to Treat External Genital Warts | NCT01943630 | External Genita... | 15% AS101 gel Vehicle | 18 Years - | BioMAS Ltd | |
| Bioequivalence Study to Compare Sol-Gel Technologies' 5-FU Cream With Efudex® (5-FU) Cream | NCT03727074 | Actinic Keratos... | 5-FU Cream Efudex® Vehicle | 18 Years - | Sol-Gel Technologies, Ltd. | |
| The Effect of Topical Imipramine on Pain and Effectiveness of Topical Photodynamic Therapy | NCT05688904 | Imipramine Photodynamic Th... Actinic Keratos... | Imipramine Vehicle | 18 Years - | Wright State University | |
| Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV) | NCT02535104 | Condylomata Acu... Papillomavirus ... Sexually Transm... | Ranpirnase Vehicle | 18 Years - 60 Years | Tamir Biotechnology, Inc. | |
| RZL-012 for Dercum's Disease Lipomas | NCT04229030 | Dercum's Diseas... | RZL-012 Vehicle | 18 Years - 70 Years | Raziel Therapeutics Ltd. | |
| A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients | NCT00961896 | Treatment for B... | Vehicle LDE225 0.25% LDE225 0.75% | 18 Years - 75 Years | Novartis | |
| A Study of A-101 Topical Solution for the Treatment of Common Warts | NCT03691831 | Common Wart | Active Vehicle | 2 Years - | Aclaris Therapeutics, Inc. | |
| Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV) | NCT02535104 | Condylomata Acu... Papillomavirus ... Sexually Transm... | Ranpirnase Vehicle | 18 Years - 60 Years | Tamir Biotechnology, Inc. | |
| Evaluation of Safety and Efficacy of BF-200 ALA for the Treatment of Actinic Keratosis With Photodynamic Therapy | NCT02799069 | Actinic Keratos... | BF-200 ALA MAL Cream Vehicle | 18 Years - 85 Years | Biofrontera Bioscience GmbH |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
